Select Page

Press Release

Bridging the gap between topical gels and injectable carpules for a new standard in patient comfort and efficiency


The evolution of dental anesthesia is entering a new era with the introduction of LQS, Lidocaine QuickStrip™, a cutting-edge muco-adhesive oral thin film developed by Rapid Dose Therapeutics (RDT; CSE: DOSE) in partnership with Skycare Compounding Labs. Utilizing proprietary QuickStrip™ technology, LQS bridges the gap between conventional topical gels and injectable carpules, offering precise, pain-free, and rapid-onset anesthesia directly to the oral mucosa, potentially reducing patient anxiety and enhancing clinical efficiency.

In his article, Dr. Gary Glassman, DDS, FRCD(C), an esteemed endodontic specialist in Toronto, Ontario, explores how LQS is revolutionizing dental practice efficiency by providing a deeper, longer-lasting effect.

Read the full article.
Bridging the Gap Between Topical Gels and Injectable Carpules for a New Standard in Patient Comfort and Efficiency


Back to press releases page